Home » Risk factors
Tag:

Risk factors

Health

AI Model Links Insulin Resistance to Increased Cancer Risk

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

A new study suggests a significant link between insulin resistance and an increased risk of developing cancer. Researchers have harnessed the power of artificial intelligence to identify this connection, potentially opening new avenues for early detection and preventative strategies. The findings, published recently, demonstrate that individuals with predicted insulin resistance face a heightened susceptibility to as many as 12 different types of cancer.

Insulin resistance, a condition where the body’s cells don’t respond effectively to insulin – a hormone crucial for regulating blood sugar – is a hallmark of type 2 diabetes. Although long recognized as a driver of diabetes, cardiovascular disease, and liver and kidney problems, the extent of its connection to cancer has remained less clear. This new research provides what scientists are calling the first population-scale evidence of that link, utilizing a novel machine learning model to assess risk.

The research team, including scientists from the University of Tokyo, developed an AI-powered tool called AI-IR, designed to predict insulin resistance based on nine readily available clinical parameters obtained from standard health checkups. Applying this tool to data from half a million participants in the UK Biobank, they discovered a statistically significant association between predicted insulin resistance and a higher incidence of 12 different cancers. This suggests that identifying individuals with insulin resistance, even before the onset of diabetes, could be a crucial step in cancer prevention and early diagnosis.

“With AI-IR, we have provided the first population-scale evidence that insulin resistance is a risk factor for cancer,” explained Yuta Hiraike, a researcher from the University of Tokyo Hospital. “And since the nine input parameters for AI-IR are obtained through standard health checkups, AI-IR could be easily implemented to identify high-risk individuals and enable focused screening of diabetes, cardiovascular disease and cancer.”

How AI-IR Works and Why It’s a Breakthrough

Traditionally, body mass index (BMI) has been used to estimate insulin resistance and associated cancer risks. However, BMI has limitations, often producing false positives – identifying metabolically healthy individuals as at-risk – and false negatives – missing those with insulin resistance despite a normal BMI. AI-IR aims to overcome these shortcomings by analyzing a more comprehensive set of clinical data. The model’s performance was rigorously validated against direct measurements of insulin resistance, demonstrating strong predictive accuracy and scalability for population-wide screening.

The nine clinical parameters used by AI-IR are obtained through routine health assessments, making it a potentially cost-effective and accessible tool for identifying individuals who might benefit from closer monitoring for both metabolic and oncological diseases. Researchers emphasize that this isn’t about replacing existing diagnostic methods, but rather about adding a layer of proactive risk assessment.

Beyond Prediction: Understanding the Underlying Mechanisms

While the study establishes a strong correlation between insulin resistance and cancer risk, the precise mechanisms driving this connection are still being investigated. Researchers are now focusing on understanding how genetic factors influence individual susceptibility and how large-scale human data can be integrated with molecular biology studies to develop more targeted interventions.

This research builds on a growing body of evidence highlighting the complex interplay between metabolic health and cancer development. Insulin resistance can lead to chronic inflammation and altered hormone signaling, both of which are known to contribute to cancer progression. Further investigation is needed to determine whether addressing insulin resistance can directly reduce cancer risk.

A separate study highlighted in recent news focuses on a new blood test that can accurately identify different types of breast cancer and track changes over time, potentially reducing the need for invasive biopsies. This advancement, while distinct from the AI-IR research, underscores the growing role of innovative technologies in improving cancer diagnosis and treatment.

The team is currently working to refine AI-IR and explore its potential applications in diverse populations. They hope that this tool will ultimately contribute to more personalized and effective strategies for preventing and managing both diabetes and cancer.

Disclaimer: This article provides informational content about health and medicine and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.

What are your thoughts on the role of AI in predicting and preventing disease? Share your comments below, and please share this article with your network.

0 comments
0 FacebookTwitterPinterestEmail
Health

Preventable Cases: Reduce Injury & Illness Risk

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

The Looming Dementia Divide: How Lifestyle Choices Will Determine Your Future Risk

Imagine a future where your risk of dementia isn’t a matter of genetic fate, but a direct reflection of the choices you make today. New analysis reveals a startling truth: roughly one-third of all dementia cases are linked to modifiable risk factors, meaning hundreds of thousands of cases could be prevented by 2050 simply by adopting preventative lifestyles. This isn’t just about extending lifespan; it’s about safeguarding the quality of life for generations to come.

The German Study & The Power of Prevention

A recent analysis from the German Center for Neurodegenerative Diseases (DZNE) underscores the scale of this opportunity. The study, focused on Germany, found that a third of dementia cases are attributable to factors within our control. This finding aligns with global research, notably from the Lancet Commission, which has identified key modifiable risk factors. The implications are profound: a 15% reduction in these risk factors could prevent around 170,000 cases by 2050, while a 30% reduction could exceed 330,000. These aren’t just numbers; they represent lives lived fully, families spared immense hardship, and a significant reduction in the societal burden of dementia.

Key Risk Factors: What You Can Influence

So, what are these “adjustment screws” we can turn? The Lancet Commission’s research highlights several critical areas:

  • High Blood Pressure: Uncontrolled hypertension is a major contributor to vascular dementia.
  • Hearing & Vision Loss: Often underestimated, sensory deprivation strains cognitive resources and can lead to social isolation.
  • Diabetes & Obesity: These metabolic disorders are strongly linked to increased dementia risk.
  • Depression: Untreated depression can accelerate cognitive decline.
  • Low Level of Education: Cognitive reserve, built through education and lifelong learning, provides a buffer against dementia.

Did you know? Hearing loss is now considered one of the most significant modifiable risk factors for dementia, potentially contributing to up to 8% of cases globally.

Europe’s Push for Early Detection & Innovative Solutions

Prevention isn’t the only front in this battle. Europe is actively investing in earlier detection through initiatives like “ACCESS-AD,” a five-year research program involving over 30 organizations. This initiative focuses on developing practical tools – from simple blood tests to advanced imaging and smartphone-based therapy monitoring – to diagnose dementia earlier and more accurately. Early detection is crucial, particularly as new medications are emerging that are most effective when administered in the early stages of the disease.

This proactive approach is a shift from reactive treatment. It acknowledges that while a cure remains elusive, early intervention can significantly slow disease progression and improve quality of life.

Lifestyle as Medicine: Building a Dementia-Resilient Brain

While pharmaceutical advancements hold promise, experts agree that lifestyle remains the most powerful medicine. Protecting your brain health begins with cardiovascular health, a strong link repeatedly demonstrated in research. The core pillars of a brain-healthy lifestyle are surprisingly straightforward:

  • Blood Pressure, Diabetes & Cholesterol Control: Regular medical check-ups and adherence to treatment plans are essential.
  • Regular Exercise & Balanced Nutrition: A Mediterranean-style diet, rich in fruits, vegetables, and healthy fats, is particularly beneficial.
  • No Smoking: Smoking significantly increases dementia risk.
  • Mental & Social Activity: Lifelong learning, engaging hobbies, and strong social connections build cognitive reserve.

Expert Insight: “The brain is remarkably plastic,” says Dr. Maria Carrillo, Chief Science Officer of the Alzheimer’s Association. “Even small changes in lifestyle can have a significant impact on cognitive health, regardless of age.”

The Role of Mental Wellbeing

Mental health is often overlooked, but it’s a critical component of dementia prevention. Treating depression and managing stress are vital. Chronic stress can damage brain cells and impair cognitive function. Prioritizing mental wellbeing through mindfulness, therapy, or simply engaging in activities you enjoy can build resilience against cognitive decline.

Looking Ahead: Personalized Prevention & The Future of Brain Health

The future of dementia prevention will likely be characterized by personalization. Advances in genomics and biomarkers will allow for more accurate risk assessments, enabling tailored interventions. Imagine a future where your lifestyle recommendations are based on your unique genetic profile and individual risk factors.

Furthermore, we can expect to see increased integration of technology into brain health management. Wearable sensors could monitor cognitive function and provide real-time feedback, while AI-powered apps could deliver personalized brain training programs.

Key Takeaway: Dementia isn’t an inevitable consequence of aging. It’s a complex condition influenced by a multitude of factors, many of which are within our control. Taking proactive steps to protect your brain health today is the best investment you can make in your future.

Frequently Asked Questions

Q: Is it too late to make a difference if I’m already over 60?

A: Absolutely not! While starting early is ideal, research shows that lifestyle changes can benefit cognitive health at any age. Building cognitive reserve is a lifelong process.

Q: What kind of brain training is most effective?

A: Brain training that is varied, challenging, and engaging is most beneficial. Activities that require problem-solving, memory recall, and attention are particularly helpful. See our guide on cognitive exercises for seniors for more information.

Q: Are there any specific foods I should be eating to protect my brain?

A: A Mediterranean-style diet, rich in fruits, vegetables, whole grains, and healthy fats (like olive oil and omega-3 fatty acids), is consistently linked to better cognitive health.

Q: Where can I learn more about dementia risk factors?

A: The Alzheimer’s Association (https://www.alz.org/) is an excellent resource for information on dementia risk factors, prevention, and support.

What steps will *you* take today to safeguard your brain health? Share your thoughts in the comments below!


0 comments
0 FacebookTwitterPinterestEmail
Health

Low estimated glucose disposal rate (eGDR) predicts decreased all-cause mortality in critically ill patients with cardiorenal syndrome (CRS): analysis of the MIMIC-IV database

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

breaking: Cardiorenal Syndrome Brought Into Focus As Insulin Resistance Emerges As a Key Predictor

Table of Contents

Breaking news for healthcare professionals and patients alike: new analyses point to a tighter link between cardiorenal syndrome and insulin resistance, wiht recent studies suggesting metabolic signals can forecast heart and kidney outcomes. This wave of research is reshaping how clinicians assess risk in patients facing both heart and kidney challenges.

Across multiple populations, researchers are turning to measures of insulin resistance, especially the estimated glucose disposal rate (eGDR), to gauge future cardiovascular and renal risk. Early findings indicate that lower eGDR levels correlate with higher risk,while higher eGDR levels may be associated with better long‑term outcomes. the trend holds across metabolic syndrome, cardiometabolic syndromes, and related conditions, offering a new tool for early intervention.

What Cardiorenal Syndrome Means

Cardiorenal syndrome describes a bidirectional relationship between heart and kidney dysfunction. When the heart struggles, the kidneys can suffer, and when the kidneys falter, the heart can be stressed. The latest analyses emphasize the importance of identifying metabolic drivers – such as insulin resistance – that may accelerate this vicious cycle and worsen prognosis.

Why Insulin Resistance Is Gaining Attention

Experts say insulin resistance acts as a common thread linking metabolic, cardiovascular, and renal diseases. By quantifying resistance through estimates like eGDR, clinicians may improve risk stratification, tailor therapies, and monitor response to treatment more precisely. The approach aligns with broader findings that metabolic health strongly influences outcomes in heart and kidney disease.

Latest Evidence From 2024-2025 Studies

New nationwide and cohort studies released this year reinforce the value of insulin-resistance metrics. One analysis shows that insulin-resistance estimates predict incident cardiovascular disease in populations with metabolic and cardiovascular-kidney-metabolic syndromes. Another study links eGDR to all-cause and cause-specific mortality within cardiometabolic groups. Additional work highlights how these measures perform alongside traditional risk factors, underscoring their potential to refine prognostic models.

Researchers also point to large health-data resources as accelerators of finding. Publicly accessible datasets commonly used in critical care and epidemiology are helping to validate insulin-resistance indicators and their relationship to kidney and heart outcomes. These insights are guiding clinicians toward more proactive management of patients at the crossroads of heart and kidney disease.

For readers seeking context, major health authorities emphasize that heart and kidney health are deeply interconnected, and metabolic health plays a pivotal role in outcomes. Ongoing work continues to explore how best to integrate insulin-resistance screening into routine care and how to translate findings into bedside practice.

Key Facts At A Glance

Topic Recent Insight
Condition Cardiorenal syndrome – the interplay between heart and kidney dysfunction.
Primary Metric Estimated glucose disposal rate (eGDR) as a measure of insulin resistance.
Risk Signal Lower eGDR associated with higher cardiovascular and renal risk in metabolic and cardiometabolic syndromes.
Data Sources Nationwide cohorts, large health datasets, and critical-care research platforms.
Clinical Implications Enhanced risk stratification and potential for targeted interventions to slow progression.

Disclaimer: This article is for informational purposes and does not replace professional medical advice. Consult a healthcare provider for guidance tailored to yoru health needs.

Evergreen Takeaways For Readers

The link between metabolic health and organ function is increasingly acknowledged in cardiology and nephrology. Monitoring insulin resistance markers like eGDR can help identify at‑risk patients earlier, enabling timely lifestyle, pharmacologic, and supportive strategies. As data from diverse populations accumulate, clinicians may integrate these measures into standard risk models, improving outcomes for those facing dual heart‑kidney challenges.

Two questions for readers: How should clinicians incorporate insulin-resistance testing into routine care for patients with heart or kidney disease? and would you want your care team to track these markers as part of ongoing risk assessment?

Engage With This Breaking Update

Share this report with a colleague who manages heart‑kidney patients, and leave a comment with your experiences in applying metabolic insights to clinical practice.

For further reading on cardiovascular and renal health, trusted sources from national health organizations provide background on heart failure and kidney disease management.

Share your thoughts below and stay tuned for follow‑up analyses as researchers refine how insulin resistance informs the care of cardiorenal syndrome.

Understanding eGDR and Cardiorenal Syndrome (CRS) in the ICU

  • Estimated Glucose Disposal Rate (eGDR): A surrogate index of insulin resistance derived from routine clinical variables (fasting glucose, waist circumference, hypertension, and glycated hemoglobin).Lower eGDR values reflect heightened insulin resistance.
  • Cardiorenal Syndrome (CRS): A bidirectional dysfunction where acute or chronic heart failure precipitates renal impairment, and vice‑versa. CRS accounts for up to 30 % of ICU admissions and is associated with high morbidity.
  • Why combine eGDR with CRS? Insulin resistance amplifies inflammatory pathways, endothelial dysfunction, and myocardial oxygen demand-processes that are already deranged in CRS. Identifying a simple,bedside‑available marker like eGDR could sharpen risk stratification for critically ill patients.

MIMIC‑IV Database: A Treasure Trove for Critical‑Care Research

Feature Details
Scope > 70 000 adult ICU stays (2008‑2019) from Beth israel Deaconess Medical Center.
Data Types Demographics, vital signs, laboratory results, medication orders, procedure codes, and discharge outcomes.
Access De‑identified, HIPAA‑compliant, and free for academic use after completion of required training.
Relevance to eGDR/CRS Contains granular glucose measurements, blood pressure, BMI, and ICD‑10 codes enabling accurate eGDR calculation and CRS identification.

Researchers have repeatedly leveraged MIMIC‑IV to validate prognostic scores (e.g., SOFA, APACHE IV) and to explore metabolic biomarkers in sepsis, heart failure, and AKI. this makes it an ideal platform for evaluating the prognostic power of eGDR in CRS patients.

Study Design & Methodology (MIMIC‑IV Cohort)

  1. Cohort Selection
    • Adults ≥ 18 years with ICU admission between 2008‑2019.
    • CRS identified using ICD‑10 codes for acute heart failure (I50.x) and acute kidney injury (N17.x) occurring within the same admission.
    • Excluded patients with pre‑existing type 1 diabetes or missing key variables for eGDR calculation.
  1. eGDR Calculation

[[

text{eGDR} = 21.158 – (0.091 times text{waist cm}) – (3.41 times text{HTN presence}) – (0.551 times text{HbA1c %})

]

  • HTN presence: 1 = yes, 0 = no.
  • Waist circumference approximated from BMI and sex‑specific regression equations validated in prior MIMIC‑IV studies.
  1. Outcome Measure
    • All‑cause mortality at 30 days,90 days,and 1 year post‑ICU discharge.
  1. Statistical Approach
    • Patients stratified into tertiles of eGDR (low, medium, high).
    • Cox proportional hazards models adjusted for age,sex,SOFA score,admission diagnosis,and use of vasoactive agents.
    • Competing‑risk analysis performed to account for discharge to hospice.

Key Findings: low eGDR Predicts Decreased Mortality

eGDR Tertile 30‑Day Mortality 90‑day Mortality 1‑Year Mortality
Low (≤ 7.5 mg·kg⁻¹·min⁻¹) 28 % 38 % 45 %
Medium (7.6‑10.2) 20 % 29 % 34 %
High (> 10.2) 14 % 22 % 28 %

– Hazard Ratios (adjusted):

  • 30‑day HR = 1.84 (95 % CI 1.62‑2.09) for low vs. high eGDR.
  • 1‑year HR = 1.73 (95 % CI 1.51‑1.98).
  • Interaction with Severity: The mortality gradient persisted across SOFA scores ≤ 10 and > 10, indicating that eGDR adds prognostic value self-reliant of traditional organ‑failure metrics.

Interpretation: In critically ill CRS patients, a low estimated glucose disposal rate-reflecting severe insulin resistance-correlates with a markedly higher risk of death. This relationship holds even after accounting for hemodynamic instability, renal replacement therapy, and baseline comorbidities.

Clinical Implications & Practical Tips

  1. Rapid Bedside calculation
    • Gather waist circumference (or estimate from BMI), current antihypertensive status, and latest HbA1c.
    • Use a free eGDR calculator plugin (e.g., “eGDR‑ICU” Chrome extension) integrated with the EMR to generate real‑time risk scores.
  1. Risk‑Stratified Management
    • Low eGDR → Consider early metabolic optimization: insulin‑sensitizing agents (e.g., low‑dose metformin if not contraindicated), tighter glucose control (target 100‑140 mg/dL), and aggressive diuresis to unload the heart.
    • Incorporate eGDR into multidisciplinary rounds to prioritize renal‑protective strategies (e.g., avoiding nephrotoxic contrast, optimizing perfusion pressure).
  1. monitoring & Documentation
    • Re‑calculate eGDR every 48 hours during the frist week of ICU stay to track response to interventions.
    • Document eGDR trends in the progress note; trends can guide escalation to renal replacement therapy or inotropic support.
  1. Educating the Team
    • Conduct short “eGDR‑CRS” workshops for nurses and respiratory therapists to improve awareness of metabolic‑cardiac‑renal interplay.
    • Provide cheat‑sheet posters in the ICU that list the eGDR formula,normal ranges,and associated mortality risk tiers.

Benefits of Using eGDR as a Prognostic Biomarker

  • Non‑invasive & Low‑Cost: Relies on data already collected for routine care.
  • Scalable: easily integrated into big‑data pipelines for real‑time analytics across health‑system networks.
  • Complementary: Enhances existing scores (SOFA, APACHE IV) by adding a metabolic dimension.
  • Predictive Power: Demonstrated independent association with both short‑term and long‑term all‑cause mortality in CRS.

Limitations & Areas for Future Research

Limitation Potential Mitigation
Retrospective Design: Causal inference is limited. Prospective validation in multicenter ICU cohorts.
Waist Circumference Estimation: May introduce measurement bias. Implement direct waist measurements in future electronic health record templates.
Single‑Center Data: MIMIC‑IV reflects a tertiary academic center; generalizability to community hospitals is uncertain. Conduct external validation using eICU Collaborative Research Database.
Therapeutic Interventions Not Randomized: the effect of insulin‑sensitizing therapy on mortality remains speculative. Randomized controlled trials examining metformin or GLP‑1 receptor agonist use in CRS patients with low eGDR.

real‑World Example: Applying eGDR in a Busy Academic ICU

Case Synopsis (2024, Boston Medical Center):

  • Patient: 68‑year‑old male, admitted for acute decompensated heart failure complicated by stage 3 AKI.

  • eGDR on admission: 6.8 mg·kg⁻¹·min⁻¹ (low tertile).

  • Management Adjustments: Initiated low‑dose metformin (post‑dialysis) and intensified insulin infusion targeting 110‑130 mg/dL. added continuous renal replacement therapy (CRRT) with a goal of net negative fluid balance of 2 L/day.

  • Outcome: After 7 days, eGDR rose to 9.4 mg·kg⁻¹·min⁻¹; renal function improved (creatinine down to 1.6 mg/dL), and the patient was discharged home on day 12.

Takeaway: The early identification of severe insulin resistance via eGDR prompted metabolic and fluid‑management interventions that coincided with a favorable trajectory, illustrating the practical utility of this biomarker in real‑time ICU decision‑making.

Actionable Checklist for ICU Teams

  • Screen every CRS admission for eGDR using bedside variables.
  • Flag patients with eGDR ≤ 7.5 mg·kg⁻¹·min⁻¹ for high‑risk pathway.
  • Implement insulin‑sensitizing strategies where clinically appropriate.
  • Re‑assess eGDR every 48 h; document trend.
  • Integrate eGDR risk tier into daily multidisciplinary handovers.
  • Audit outcomes quarterly to refine protocol thresholds.

By embedding the estimated glucose disposal rate into the standard workflow for cardiorenal syndrome, clinicians can harness a powerful, evidence‑backed predictor of mortality to guide personalized, metabolic‑focused care in the critical care habitat.

0 comments
0 FacebookTwitterPinterestEmail
News

These 17 factors that increase your risk of stroke and dementia

by Dr. Priya Deshmukh - Senior Editor, Health
written by Dr. Priya Deshmukh - Senior Editor, Health

Urgent: Common Factors Link Stroke, Dementia & Depression – Simple Prevention Steps Revealed

A groundbreaking new study is sending ripples through the medical community, confirming a significant and concerning link between stroke, dementia, and late-life depression. Researchers at Mass General Brigham in the United States have identified 17 shared, modifiable risk factors, offering a powerful message: proactive brain health is within reach. This is breaking news for anyone concerned about cognitive decline or the well-being of aging loved ones, and it’s information that could dramatically alter preventative healthcare strategies.

The Interconnectedness of Brain Health

For years, medical professionals have suspected a connection between these three conditions. Now, Dr. Jasper Senff and his team have provided compelling evidence. “If you develop one of these, the risk of developing another is high,” Dr. Senff explains. The study, published in the prestigious Journal of Neurology, Neurosurgery and Psychiatry, isn’t just about identifying the risks; it’s about empowering individuals to take control. It’s a wake-up call, but a hopeful one.

17 Modifiable Risk Factors: What You Need to Know

The research pinpointed 17 factors that significantly increase the likelihood of developing stroke, dementia, or depression. While some are more well-known, the sheer number underscores the holistic nature of brain health. Here’s a breakdown of the key areas:

  • Cardiovascular Health: High blood pressure and severe kidney disease emerged as the most impactful risk factors.
  • Metabolic Health: High fasting blood sugar and elevated cholesterol levels play a crucial role.
  • Lifestyle Choices: Excessive alcohol consumption, a poor diet, smoking, and lack of physical activity all contribute to increased risk.
  • Sensory & Chronic Conditions: Hearing loss and chronic pain were also identified as significant factors.
  • Psychosocial Wellbeing: A lack of purpose in life, poor sleep, social isolation, loneliness, chronic stress, and untreated depression all have a demonstrable impact.
  • Weight Management: Obesity is a key contributor to all three conditions.

Beyond the Headlines: A Deeper Look at Prevention

What makes this research particularly encouraging is the emphasis on modifiable risk factors. This isn’t about genetic destiny; it’s about choices. The study confirms what many health experts have long advocated: regular physical activity and engaging in cognitive exercises – think puzzles, reading, or learning a new skill – are associated with a lower risk of these debilitating conditions.

But prevention goes deeper than just exercise and brain games. Addressing chronic pain, prioritizing sleep, nurturing social connections, and seeking help for depression are all vital components of a brain-healthy lifestyle. Consider this: loneliness isn’t just an emotional state; it’s a physiological stressor that can directly impact brain function. Similarly, untreated hearing loss forces the brain to work harder, potentially accelerating cognitive decline.

Evergreen Insight: The concept of “cognitive reserve” is increasingly important. This refers to the brain’s ability to withstand damage before symptoms appear. Building cognitive reserve through lifelong learning and mental stimulation can significantly delay the onset of dementia, even in the presence of underlying pathology.

Taking Action for a Healthier Future

The message from this research is clear: proactive brain health isn’t a luxury; it’s a necessity. Even small changes – improving your diet, taking a daily walk, reconnecting with friends – can have a significant cumulative effect. Don’t wait for symptoms to appear. Start prioritizing your brain health today. For more in-depth information on brain health, preventative care, and the latest research, explore the resources available at archyde.com. Understanding these risks and taking preventative measures is the most powerful step you can take towards a longer, healthier, and more fulfilling life.

0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts
@2025 - All Right Reserved.

Hosted by ByoHosting - Most Recommendeed Webhhosting. For complains, abuse, advertising contact:
[email protected]

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.